Evidence map›Paper›PMID 39410054›Full record

ArticleCancers2024

Correction: Chisholm et al. Frontline and Relapsed Rhabdomyosarcoma (FaR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG).

Julia Chisholm, Henry Mandeville, Madeleine Adams, Veronique Minard-Collin, Timothy Rogers, Anna Kelsey, Janet Shipley, Rick R van Rijn, Isabelle de Vries, Roelof van Ewijk and 17 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

27 authors.

Julia ChisholmChildren and Young People's Unit, Royal Marsden Hospital and Institute of Cancer Research, Sutton SM2 5PT, UK.ORCID 0000-0003-3479-7997
Henry MandevilleChildren and Young People's Unit, Royal Marsden Hospital and Institute of Cancer Research, Sutton SM2 5PT, UK.
Madeleine AdamsChildren's Hospital for Wales, Cardiff CF14 4XW, UK.
Veronique Minard-CollinDepartment of Paediatric Oncology, Gustave Roussy, 75015 Paris, France.
Timothy RogersDepartment of Paediatric Surgery, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol BS1 3NU, UK.ORCID 0000-0002-4499-0742
Anna KelseyDepartment of Paediatric Histopathology, Royal Manchester Children's Hospital, Manchester University NHS Foundation Trust, Manchester M13 9WL, UK.
Janet ShipleyThe Institute of Cancer Research, London SW7 3RP, UK.
Rick R van RijnDepartment of Radiology and Nuclear Medicine, University of Amsterdam, Amsterdam UMC, 1081 HV Amsterdam, The Netherlands.ORCID 0000-0002-8876-6515
Isabelle de VriesPrincess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.ORCID 0000-0001-8289-4164
Roelof van EwijkPrincess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.ORCID 0000-0003-0339-6031
Bart de KeizerPrincess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.ORCID 0000-0002-6270-9483
Susanne A GatzBirmingham Women's and Children's NHS Foundation Trust, Birmingham B15 2TG, UK.
Michela CasanovaFondazione IRCCS Istituto Nazionale Tumori, 20133 Milan, Italy.ORCID 0000-0003-0368-7883
Lisa Lyngsie HjalgrimUniversity Hospital Copenhagen, DK-2200 Copenhagen, Denmark.ORCID 0000-0001-5186-3365
Charlotte FirthCancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham B15 2TT, UK.
Keith WheatleyCancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham B15 2TT, UK.
Pamela KearnsCancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham B15 2TT, UK.ORCID 0000-0003-2756-5813
Wenyu LiuCancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham B15 2TT, UK.
Amanda KirkhamCancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham B15 2TT, UK.
Helen ReesDepartment of Paediatric Oncology, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol BS1 3NU, UK.
Gianni BisognoDepartment of Women and Children's Health, University of Padova, 35122 Padua, Italy.ORCID 0000-0003-4462-5523
Ajla WastiThe Institute of Cancer Research, London SW7 3RP, UK.
Sara WakelingAlice's Arc Charity, London EC1V 1AW, UK.ORCID 0000-0002-3563-0390
Delphine HeenenKickCancer Foundation, 1000 Brussels, Belgium.ORCID 0000-0002-7703-9902
Deborah A TweddleVivo Biobank, Translational & Clinical Research Institute, Newcastle University Centre for Cancer, Newcastle University, Newcastle upon Tyne NE1 7RU, UK.ORCID 0000-0003-2208-3970
Johannes H M MerksPrincess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.ORCID 0000-0001-7659-1028
Meriel JenneyChildren's Hospital for Wales, Cardiff CF14 4XW, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The authors wish to make corrections to the authorship and title of [...].

Identifiers

PMID39410054
PMCPMC11476104

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.